Enfusion (NYSE:ENFN) Stock Price Up 4.3%

Enfusion, Inc. (NYSE:ENFN - Get Free Report) shares were up 4.3% during mid-day trading on Monday . The company traded as high as $9.38 and last traded at $9.37. Approximately 229,194 shares changed hands during trading, a decline of 40% from the average daily volume of 380,004 shares. The stock had previously closed at $8.98.

Enfusion Stock Performance

The stock's 50 day moving average price is $8.53 and its 200-day moving average price is $8.88. The company has a market cap of $1.22 billion, a PE ratio of 299.33, a PEG ratio of 2.23 and a beta of 0.90.

Enfusion (NYSE:ENFN - Get Free Report) last released its quarterly earnings data on Tuesday, August 6th. The company reported $0.02 EPS for the quarter, missing the consensus estimate of $0.03 by ($0.01). The company had revenue of $49.46 million during the quarter, compared to analysts' expectations of $50.27 million. Enfusion had a return on equity of 6.17% and a net margin of 1.98%. On average, analysts anticipate that Enfusion, Inc. will post 0.07 EPS for the current year.

Institutional Investors Weigh In On Enfusion

A number of large investors have recently added to or reduced their stakes in ENFN. Swiss National Bank boosted its position in Enfusion by 17.4% during the 4th quarter. Swiss National Bank now owns 58,100 shares of the company's stock valued at $564,000 after acquiring an additional 8,600 shares in the last quarter. Azora Capital LP purchased a new stake in shares of Enfusion during the fourth quarter valued at $134,000. Scalar Gauge Management LLC purchased a new position in Enfusion in the 4th quarter worth about $1,993,000. Brown Capital Management LLC lifted its stake in Enfusion by 6.5% during the 4th quarter. Brown Capital Management LLC now owns 11,817,661 shares of the company's stock valued at $114,631,000 after acquiring an additional 724,502 shares during the period. Finally, Wellington Management Group LLP boosted its holdings in shares of Enfusion by 5.7% during the 4th quarter. Wellington Management Group LLP now owns 489,364 shares of the company's stock valued at $4,747,000 after acquiring an additional 26,464 shares during the last quarter. Institutional investors own 81.05% of the company's stock.

Enfusion Company Profile

Enfusion, Inc provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company provides Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.